Maryland Company Gets $1.6 Billion From US Government for COVID-19 Vaccine Development
Novavax Inc., a biotechnology company based in Gaithersburg, Maryland, has received $1.6 billion from the federal government to develop, test and manufacture its COVID-19 vaccine c…